Review
Jul 2026
Immuno-metabolic reprogramming in pulmonary fibrosis: Emerging therapeutic targets beyond inflammation.
New evidence supports metabolic crosstalk between immune cells and fibroblasts as a key mechanism driving fibrotic remodeling and highlights immunometabolic regulation as a promising therapeutic framework and identifies opportunities for precision-based interventions in pulmonary fibrosis.
Hemraj Singh, Anushka Purwar, R. Taliyan
· International Immunopharmaco... · 0 citations